Emax Value
Emax Value - Related Videos
11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
0 Views •
Cited by 10 •
2011
A method for estimating the affinity constant of an agonist for the active state (Kb) of a G protein-coupled receptor is described. The analysis provides absolute or relative measures of Kb depending on whether constitutive receptor activation is measurable. Our method applies to various responses downstream from receptor activation.
07:20
Observing the Transformation of Bodily Self-consciousness in the Squeeze-machine Experiment
0 Views •
Cited by 6 •
2019
The squeeze machine, a V-shaped device that provides pressure along the whole body is used in therapy especially for people with autism. Here, we focus on its possible use in experiments to capture the typical transformations of bodily self-consciousness with peri-personal space measurement.
FAQs
The Emax Value describes the response ceiling, whereas potency is inferred from the dose or concentration needed to produce a specified fraction of that ceiling. Consequently, a drug may reach a larger maximum effect yet require greater exposure to achieve it, or reach a smaller maximum effect at lower exposure. These measurements answer different pharmacological questions.
A plateau indicates that additional increases in dose or concentration no longer produce progressively larger measured responses. In an Emax analysis, this upper region is essential because it identifies the maximum effect used for efficacy comparisons. If the relationship has not approached a plateau, the available data may not establish the drug’s full response capacity.
Receptor-mediated responses connect the measured effect to pharmacological activity observed in experimental or clinical research. Examining the resulting exposure-response relationship allows investigators to determine how response increases and where it levels off. The resulting Emax value helps characterize the response system and compare how effectively different drugs produce the measured pharmacological outcome.
Investigators first measure a drug effect across increasing doses or concentrations, then organize the observations as a dose-response or concentration-response relationship. They identify the point at which responses reach a plateau and use the plateau level as the Emax value. Repeating this analysis across drugs permits direct comparison of their observed maximum effects.
When two drugs are evaluated, their Emax values provide a basis for comparing the largest observed effects, while the exposure associated with a selected fraction of Emax provides potency information. Considering both prevents investigators from treating a high maximum effect and a low required exposure as equivalent properties. This distinction improves interpretation of therapeutic comparisons.
The approach is useful in experimental and clinical pharmacology when investigators need to characterize drug effects, compare therapeutic candidates, or interpret receptor-mediated responses. It organizes observed effects around the maximum response and the exposure-response pattern, helping researchers distinguish differences in efficacy from differences in potency during drug characterization and therapeutic comparison.